Ipratropium Bromide Spray, Metered
Product Images NDC 60505-0826
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Ipratropium Bromide (NDC 60505-0826). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Fig2 (Fig2)
Fig3 (Fig3)
Fig4 (Fig4)
Ipra-naso-0-03pct-btl (Ipra Naso 0 03pct Btl)
This is a description for a medication with the NDC number 60505-0826-1. The medication comes in a 30mL bottle and contains 0.2% of ipratropium bromide. The medication is intended for nasal use. The label also provides instructions for storage at room temperature and usage directions, which are not specified in the provided text. The company or manufacturer of the medication is named as Spotec and they are located in Toronto, Canada.*
Ipra-naso-0-03pct-ctn (Ipra Naso 0 03pct Ctn)
This is a description of a medication named Ipratropium Bromide Nasal Solution, which is available in spray form. It comes in a bottle with 345 measured sprays, and the usual dosage is two sprays per nostril, two or three times a day. The solution contains 0.3% of ipratropium bromide in an aqueous solution. It also includes benzalkonium chloride, cetylepyridinium chloride, purified water, and sodium chloride. The medication should be stored between 21-25°C and must be avoided by freezing. Full prescribing information and patient instructions detailing how to use the solution should be read before use. The medication is manufactured by Apotex Inc. of Toronto, Canada, for Apotex Corp. located in Weston, Florida.*
Ipratropium-structure (Ipratropium)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.